Fatty acid-binding protein, liver

BE0003998ProteinHumansFABP1

Plays a role in lipoprotein-mediated cholesterol uptake in hepatocytes (PubMed:25732850). It is acted on by 7 drugs in DrugBank.

Gene name
FABP1
UniProtKB entry
P07148Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
127 residues · 14,208 Da
Also known as
FABPL · Fatty acid-binding protein 1 · L-FABP · Liver-type fatty acid-binding protein

Resolves to

Protein
UniProtP07148UniProt nameFABPL_HUMAN
Gene
HGNCHGNC:3555NCBI Gene2168GenBank182358GeneCardsFABP1
Pharmacology
KEGGhsa:2168
Structure
PDB2F73PDB2L67PDB2L68
Drugs

What you can answer from here — as of September 07, 2019

7DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
10GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
17+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Fatty acid-binding protein, liver, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In